Dr Edward Cha | Associate Medical Director

Dr Edward Cha, Associate Medical Director, Genentech

Dr. Edward Cha is an Associate Medical Director in the Cancer Immunotherapy
Franchise within Product Development Oncology at Genentech, South San
Francisco. He received an AB degree in Molecular Biology from Princeton University,
and MD/PhD degrees at Columbia University, New York. He completed his medical
residency at The Mount Sinai Hospital in New York. Prior to his current position, he
was an oncology and postdoctoral fellow at the University of California, San
Francisco, where he focused on melanoma, combination therapies, cancer immunity
and biologic markers of response to immune therapies. At Genentech, Ed is
developing novel cancer immunotherapy combinations in solid tumors.


Agenda Day 1 @ 12:45

Insights into combination studies across various tumour types

  • The rational for pursuing combination therapy, the number of combinations currently being pursued
  • Examples of current combinations with TECENTRIQ and other partner molecules
  • Challenges associated with developing combination clinical trial studies – should we change how these trials are designed?

back to speakers